{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:16:19Z","timestamp":1767176179087,"version":"build-2238731810"},"update-to":[{"DOI":"10.1371\/journal.pmed.1003768","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000}}],"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R183-A11333"],"award-info":[{"award-number":["R183-A11333"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005860","name":"Helsefonden","doi-asserted-by":"publisher","award":["17-B-0094"],"award-info":[{"award-number":["17-B-0094"]}],"id":[{"id":"10.13039\/501100005860","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Public trust in the human papilloma virus (HPV) vaccination programme has been challenged by reports of potential severe adverse effects. The reported adverse symptoms were heterogeneous and overlapping with those characterised as chronic fatigue syndrome (CFS) and have been described as CFS-like symptoms. Evidence suggests that CFS is often precipitated by an infection. The aim of the study was to examine if an infection in temporal proximity to HPV vaccination is a risk factor for suspected adverse effects following HPV vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>\n                      The study was a nationwide register-based cohort study and case-crossover analysis. The study population consisted of all HPV vaccinated females living in Denmark, born between 1974 and 2006, and vaccinated between January 1, 2006 and December 31, 2017. The exposure was any infection in the period \u00b1 1 month around time of first HPV vaccination and was defined as (1) hospital-treated infection; (2) redemption of anti-infective medication; or (3) having a rapid streptococcal test done at the general practitioner. The outcome was referral to a specialised hospital setting (5 national HPV centres opened June 1, 2015) due to suspected adverse effects following HPV vaccination. Multivariable logistic regression was used to estimate the association between infection and later HPV centre referral. The participants were 600,400 HPV-vaccinated females aged 11 to 44 years. Of these, 48,361 (9.7%) females had a hospital-treated infection, redeemed anti-infective medication, or had a rapid streptococcal test \u00b1 1 month around time of first HPV vaccination. A total of 1,755 (0.3%) females were referred to an HPV centre. Having a hospital-treated infection in temporal proximity to vaccination was associated with significantly elevated risk of later referral to an HPV centre (odds ratio (OR) 2.75, 95% confidence interval (CI) 1.72 to 4.40;\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001). Increased risk was also observed among females who redeemed anti-infective medication (OR 1.56, 95% CI 1.33 to 1.83;\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001) or had a rapid streptococcal test (OR 1.45, 95% CI 1.10 to 1.93;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.010). Results from a case-crossover analysis, which was performed to adjust for potential unmeasured confounding, supported the findings. A key limitation of the study is that the HPV centres did not open until June 1, 2015, which may have led to an underestimation of the risk of suspected adverse effects, but stratified analyses by year of vaccination yielded similar results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Treated infection in temporal proximity to HPV vaccination is associated with increased risk for later referral with suspected adverse vaccine effects. Thus, the infection could potentially be a trigger of the CFS-like symptoms in a subset of the referred females. To our knowledge, the study is the first to investigate the role of infection in the development of suspected adverse effects after HPV vaccination and replication of these findings are needed in other studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1003768","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T13:32:53Z","timestamp":1631107973000},"page":"e1003768","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Infections in temporal proximity to HPV vaccination and adverse effects following vaccination in Denmark: A nationwide register-based cohort study and case-crossover analysis"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3936-6240","authenticated-orcid":true,"given":"Lene Wulff","family":"Krogsgaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0037-7524","authenticated-orcid":true,"given":"Irene","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6470-7465","authenticated-orcid":true,"given":"Oleguer","family":"Plana-Ripoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0287-3687","authenticated-orcid":true,"given":"Bodil Hammer","family":"Bech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5384-2557","authenticated-orcid":true,"given":"Tina Hovgaard","family":"L\u00fctzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9135-3474","authenticated-orcid":true,"given":"Reimar Wernich","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1518-0975","authenticated-orcid":true,"given":"Dorte","family":"Rytter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"key":"pmed.1003768.ref001","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"M Drolet","year":"2019","journal-title":"Lancet"},{"key":"pmed.1003768.ref002","doi-asserted-by":"crossref","first-page":"l1161","DOI":"10.1136\/bmj.l1161","article-title":"Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12\u201313 in Scotland: retrospective population study","volume":"365","author":"T Palmer","year":"2019","journal-title":"BMJ"},{"key":"pmed.1003768.ref003","doi-asserted-by":"crossref","first-page":"100401","DOI":"10.1016\/j.eclinm.2020.100401","article-title":"Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries","volume":"23","author":"SK Kjaer","year":"2020","journal-title":"EClinicalMedicine"},{"key":"pmed.1003768.ref004","doi-asserted-by":"crossref","unstructured":"Statens serum Institut. EPI News Week 16\/17 2019. 2019 [cited 2021 Aug 10]. Available from: https:\/\/en.ssi.dk\/news\/epi-news\/2019\/no-16-17\u20142019","DOI":"10.22233\/20412495.0319.16"},{"key":"pmed.1003768.ref005","first-page":"18","article-title":"Decline in HPV-vaccination uptake in Denmark\u2014The association between HPV-related media coverage and HPV-vaccination","author":"CH Suppli","year":"2018","journal-title":"BMC Public Health"},{"key":"pmed.1003768.ref006","first-page":"A5064","article-title":"Suspected side effects to the quadrivalent human papilloma vaccine","volume":"62","author":"L Brinth","year":"2015","journal-title":"Dan Med J"},{"key":"pmed.1003768.ref007","first-page":"CD009069","article-title":"Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors","volume":"5","author":"M Arbyn","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"pmed.1003768.ref008","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.vaccine.2017.06.031","article-title":"HPV vaccination and risk of chronic fatigue syndrome\/myalgic encephalomyelitis: A nationwide register-based study from Norway","volume":"35","author":"B Feiring","year":"2017","journal-title":"Vaccine"},{"key":"pmed.1003768.ref009","article-title":"Hospital Records of Pain, Fatigue, or Circulatory Symptoms in Girls Exposed to Human Papillomavirus Vaccination: Cohort, Self-controlled Case Series, and Population Time Trend Studies","author":"RW Thomsen","year":"2020","journal-title":"Am J Epidemiol"},{"key":"pmed.1003768.ref010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/joim.12694","article-title":"Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases","volume":"283","author":"A Hviid","year":"2018","journal-title":"J Intern Med"},{"key":"pmed.1003768.ref011","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.phrs.2018.04.007","article-title":"Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis","volume":"132","author":"J Mouchet","year":"2018","journal-title":"Pharmacol Res"},{"key":"pmed.1003768.ref012","first-page":"47","article-title":"Quadrivalent human papillomavirus vaccination in boys and risk of autoimmune diseases, neurological diseases and venous thromboembolism","author":"M Frisch","year":"2018","journal-title":"Int J Epidemiol"},{"key":"pmed.1003768.ref013","unstructured":"European Medicines Agency. HPV vaccines: EMA confirms evidence does not support that they cause CRPS or POTS. 2015 [cited 2021 Aug 10] pp. 5\u20138. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/hpv-vaccines-article-20-procedure-ema-confirms-evidence-does-not-support-they-cause-crps-pots_en.pdf"},{"key":"pmed.1003768.ref014","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jama.2014.16946","article-title":"Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system","volume":"313","author":"NM Scheller","year":"2015","journal-title":"JAMA"},{"key":"pmed.1003768.ref015","doi-asserted-by":"crossref","first-page":"m2930","DOI":"10.1136\/bmj.m2930","article-title":"Association between quadrivalent human papillomavirus vaccination and selected syndromes with autonomic dysfunction in Danish females: population based, self-controlled, case series analysis","volume":"370","author":"A Hviid","year":"2020","journal-title":"BMJ"},{"key":"pmed.1003768.ref016","doi-asserted-by":"crossref","unstructured":"European Medecines Agency, Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency. Assessment report. Review under Article 20 of Regulation (EC) No 726\/2004, human papillomavirus (HPV) vaccines. 2015. doi: 10.1007\/978-3-319-12406-3_9","DOI":"10.1007\/978-3-319-12406-3_9"},{"key":"pmed.1003768.ref017","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/cei.12043","article-title":"Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls","volume":"172","author":"AS Bradley","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"pmed.1003768.ref018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neubiorev.2019.08.011","article-title":"Inflammatory proteins are altered in chronic fatigue syndrome-A systematic review and meta-analysis","volume":"107","author":"R Strawbridge","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"pmed.1003768.ref019","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12035-013-8553-0","article-title":"The emerging role of autoimmunity in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/cfs)","volume":"49","author":"G Morris","year":"2014","journal-title":"Mol Neurobiol"},{"key":"pmed.1003768.ref020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MOP.0b013e32835c1108","article-title":"Chronic fatigue syndrome following infections in adolescents","volume":"25","author":"BZ Katz","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"pmed.1003768.ref021","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study","volume":"333","author":"I Hickie","year":"2006","journal-title":"BMJ"},{"key":"pmed.1003768.ref022","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fimmu.2018.00229","article-title":"Infection Elicited Autoimmunity and Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: An Explanatory Model","volume":"9","author":"J Blomberg","year":"2018","journal-title":"Front Immunol"},{"key":"pmed.1003768.ref023","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(06)68073-2","article-title":"Chronic fatigue syndrome","volume":"367","author":"JB Prins","year":"2006","journal-title":"Lancet"},{"key":"pmed.1003768.ref024","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/qjmed\/hci149","article-title":"Risk and predictors of fatigue after infectious mononucleosis in a large primary-care cohort","volume":"99","author":"I Petersen","year":"2006","journal-title":"QJM"},{"key":"pmed.1003768.ref025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.vaccine.2008.10.043","article-title":"Vaccination as teenagers against meningococcal disease and the risk of the chronic fatigue syndrome","volume":"27","author":"P Magnus","year":"2009","journal-title":"Vaccine"},{"key":"pmed.1003768.ref026","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.1016\/j.vaccine.2015.10.018","article-title":"Chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine","volume":"33","author":"P Magnus","year":"2015","journal-title":"Vaccine"},{"key":"pmed.1003768.ref027","volume-title":"Vaccines","author":"S Plotkin","year":"2012","edition":"6"},{"key":"pmed.1003768.ref028","unstructured":"Danish Health and Medines Authority. Vaccination af b\u00f8rn. 2019 [cited 2020 Aug 10] p. 1. Available from: https:\/\/www.sst.dk\/da\/viden\/vaccination\/vaccination-af-boern"},{"key":"pmed.1003768.ref029","unstructured":"Ezeanolue, E. Harriman, K. Hunter, P, Kroger, A, Pellegrini C. General Best Practice Guidelines for Immunization. 2018. Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/index.html"},{"key":"pmed.1003768.ref030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish National Patient Register","volume":"39","author":"E Lynge","year":"2011","journal-title":"Scand J Public Health"},{"key":"pmed.1003768.ref031","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"HW Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"key":"pmed.1003768.ref032","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/CLEP.S37587","article-title":"Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions","volume":"4","author":"SA Johannesdottir","year":"2012","journal-title":"Clin Epidemiol"},{"key":"pmed.1003768.ref033","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/eurpub\/cky088","article-title":"Socioeconomic predictors of referral to a diagnostic centre on suspected adverse events following HPV vaccination","volume":"28","author":"N Weye","year":"2018","journal-title":"Eur J Pub Health"},{"key":"pmed.1003768.ref034","unstructured":"Statens Serum Institut. Danmap 2018. In: Statens Serum Institut DTU National Food Institute [Internet]. 2019 [cited 2021 Aug 10] pp. 3\u201326. Available from: https:\/\/www.danmap.org\/reports\/2018"},{"key":"pmed.1003768.ref035","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/aje\/kwg144","article-title":"Case-crossover and case-time-control designs in birth defects epidemiology","volume":"158","author":"S Hernandez-Diaz","year":"2003","journal-title":"Am J Epidemiol"},{"key":"pmed.1003768.ref036","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/pds.3691","article-title":"Trimethoprim use before pregnancy and risk of congenital malformation: reanalyzed using a case-crossover design and a case-time-control design","volume":"23","author":"Y Sun","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"pmed.1003768.ref037","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.vaccine.2019.02.029","article-title":"Hospital contacts and diagnoses five years prior to HPV vaccination among females referred for suspected adverse vaccine effects: A Danish nationwide case-control study","volume":"37","author":"LW Krogsgaard","year":"2019","journal-title":"Vaccine"},{"key":"pmed.1003768.ref038","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/CLEP.S135318","article-title":"Psychiatric conditions and general practitioner attendance prior to HPV vaccination and the risk of referral to a specialized hospital setting because of suspected adverse events following HPV vaccination: a register-based, matched case-control study","volume":"9","author":"TH Lutzen","year":"2017","journal-title":"Clin Epidemiol"},{"key":"pmed.1003768.ref039","doi-asserted-by":"crossref","first-page":"e0162520","DOI":"10.1371\/journal.pone.0162520","article-title":"Pre-Vaccination Care-Seeking in Females Reporting Severe Adverse Reactions to HPV Vaccine. A Registry Based Case-Control Study","volume":"11","author":"K M\u00f8lbak","year":"2016","journal-title":"PLoS ONE"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1003768","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T14:42:32Z","timestamp":1632321752000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003768"}},"subtitle":[],"editor":[{"given":"Mirjam E. E.","family":"Kretzschmar","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003768","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]}}}